Theravance Biopharma
$23.069876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$23.06
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$1.93 (+9.13%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell TBPH and other stocks, options, ETFs, and crypto commission-free!
About TBPH
Theravance Biopharma, Inc. operates as a biopharmaceutical company. It focuses on the discovery, research, development, and commercialization of organ-selective medicines. Read More Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand, and neprilysin. The company was founded in July 2013 and is headquartered in George Town, Cayman Islands.
Employees
316
Headquarters
George Town, George Town
Founded
2013
Market Cap
1.40B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
510.82K
High Today
$23.21
Low Today
$21.24
Open Price
$21.24
Volume
239.35K
52 Week High
$31.54
52 Week Low
$15.18
Collections
Analyst Ratings
83%
of 6 ratings
Buy
83%
Hold
17%
Sell
0%
TBPH Earnings
-$1.32
-$0.88
-$0.44
$0.00
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 5, After Hours